These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14726530)

  • 41. Real-time analysis of the assembly of ligand, receptor, and G protein by quantitative fluorescence flow cytometry.
    Fay SP; Posner RG; Swann WN; Sklar LA
    Biochemistry; 1991 May; 30(20):5066-75. PubMed ID: 1645188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. G-protein-mediated activation of turkey erythrocyte phospholipase C by beta-adrenergic and P2y-purinergic receptors.
    Vaziri C; Downes CP
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):917-22. PubMed ID: 1352448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guanosine 5'-(gamma-[35S]thio)triphosphate autoradiography allows selective detection of histamine H3 receptor-dependent G protein activation in rat brain tissue sections.
    Laitinen JT; Jokinen M
    J Neurochem; 1998 Aug; 71(2):808-16. PubMed ID: 9681473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stable association of G proteins with beta 2AR is independent of the state of receptor activation.
    Lachance M; Ethier N; Wolbring G; Schnetkamp PP; Hébert TE
    Cell Signal; 1999 Jul; 11(7):523-33. PubMed ID: 10405763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activation.
    Zaki PA; Keith DE; Thomas JB; Carroll FI; Evans CJ
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1015-20. PubMed ID: 11504798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
    Weitl N; Seifert R
    J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between rate and extent of G protein activation: comparison between full and partial opioid agonists.
    Traynor JR; Clark MJ; Remmers AE
    J Pharmacol Exp Ther; 2002 Jan; 300(1):157-61. PubMed ID: 11752111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coordinated agonist regulation of receptor and G protein palmitoylation and functional rescue of palmitoylation-deficient mutants of the G protein G11alpha following fusion to the alpha1b-adrenoreceptor: palmitoylation of G11alpha is not required for interaction with beta*gamma complex.
    Stevens PA; Pediani J; Carrillo JJ; Milligan G
    J Biol Chem; 2001 Sep; 276(38):35883-90. PubMed ID: 11461908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.
    Ramsay D; Bevan N; Rees S; Milligan G
    Br J Pharmacol; 2001 May; 133(2):315-23. PubMed ID: 11350868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex.
    Yao XJ; Vélez Ruiz G; Whorton MR; Rasmussen SG; DeVree BT; Deupi X; Sunahara RK; Kobilka B
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9501-6. PubMed ID: 19470481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of signal-transducing guanine-nucleotide-binding regulatory proteins by guanosine 5'-[gamma-thio]triphosphate. Information transfer by intermediately thiophosphorylated beta gamma subunits.
    Wieland T; Ulibarri I; Gierschik P; Jakobs KH
    Eur J Biochem; 1991 Mar; 196(3):707-16. PubMed ID: 1901546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for receptor and G-protein regulation of a phosphatidylethanolamine-hydrolysing phospholipase A1 in guinea-pig heart microsomes: stimulation of phospholipase A1 activity by DL-isoprenaline and guanine nucleotides.
    Badiani K; Arthur G
    Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):805-9. PubMed ID: 8554524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg ; Mikaels ; Mohell N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allosteric interactions between the binding sites of receptor agonists and guanine nucleotides: a comparative study of the 5-hydroxytryptamine1A and adenosine A1 receptor systems in rat hippocampal membranes.
    Mahle CD; Wiener HL; Yocca FD; Maayani S
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1275-84. PubMed ID: 1469633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
    Chidiac P; Nouet S; Bouvier M
    Mol Pharmacol; 1996 Sep; 50(3):662-9. PubMed ID: 8794908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional binding assays for estimation of the intrinsic efficacy of ligands at the 5-HT1A receptor: application for screening drug candidates.
    Noël F; Pompeu TE; Moura BC
    J Pharmacol Toxicol Methods; 2014; 70(1):12-8. PubMed ID: 24636913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of agonist-dependent and -independent signal initiation of alpha(1b)-adrenoceptor mutants by direct analysis of guanine nucleotide exchange on the G protein galpha(11).
    Carrillo JJ; Stevens PA; Milligan G
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1080-8. PubMed ID: 12183666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
    Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):165-72. PubMed ID: 2870175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association.
    Kong H; Raynor K; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):380-4. PubMed ID: 8102784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.